Palmitoyl Tripeptide-1

Is Palmitoyl Tripeptide-1 (Pal-GHK) Effective for Anti-Aging? Benefits, Formulation & Comparison Guide Explained

Yes, Palmitoyl Tripeptide-1 (Pal-GHK) is a clinically supported cosmetic peptide with well-documented ability to stimulate collagen types I and III synthesis, improve skin firmness, and reduce the appearance of wrinkles — making it one of the most important signaling peptides in modern anti-aging formulation.

What Is Palmitoyl Tripeptide-1?

Palmitoyl Tripeptide-1 (CAS 147732-56-7) is a synthetic lipopeptide composed of three amino acids — glycine (G), histidine (H), and lysine (K) — conjugated to a palmitoyl (C16 fatty acid) chain. It is widely known by its shorthand Pal-GHK, reflecting its amino acid sequence. Its molecular formula is C₂₈H₄₉N₅O₇ with a molecular weight of approximately 578.72 g/mol.

The palmitoyl moiety serves as a lipid delivery vehicle, dramatically enhancing the peptide’s ability to penetrate the stratum corneum and reach the dermal fibroblasts where collagen synthesis occurs. Once in the dermis, Pal-GHK acts as a matrikine-mimicking signaling peptide — it mimics the natural collagen breakdown fragments that the body uses to trigger repair and regeneration, stimulating fibroblasts to produce new extracellular matrix (ECM) proteins.

Palmitoyl Tripeptide-1 is best known as one of the two active peptides in Matrixyl 3000 (the other being Palmitoyl Tetrapeptide-7), the patented peptide complex developed by Sederma (Croda International). It is available as a white to off-white powder with ≥95% purity (HPLC), water-soluble, and stable across a pH range of 4.0–7.5.

Key Benefits of Palmitoyl Tripeptide-1

Collagen Type I and III Stimulation. Palmitoyl Tripeptide-1’s primary mechanism is the stimulation of collagen types I and III synthesis in dermal fibroblasts. Collagen type I is the most abundant structural protein in the dermis, providing tensile strength and firmness. Collagen type III is associated with skin elasticity and is particularly important in younger skin. In vitro studies on cultured fibroblasts confirmed significant upregulation of both collagen types following exposure to Pal-GHK, with the peptide triggering receptor-mediated signaling pathways that mimic the body’s natural tissue repair response.

Glycosaminoglycan and Hyaluronic Acid Synthesis. Beyond collagen, Pal-GHK stimulates the production of glycosaminoglycans (GAGs), including hyaluronic acid — the key molecules responsible for skin hydration and plumpness. Increased GAG synthesis contributes to a more supple, hydrated, and volumized appearance, complementing the structural benefits of collagen stimulation.

Wrinkle Reduction and Skin Firming. By rebuilding the dermal ECM through collagen and GAG stimulation, Palmitoyl Tripeptide-1 directly addresses the structural causes of wrinkles and skin laxity. Clinical studies on Matrixyl 3000 (which contains Pal-GHK as its collagen-signaling component) report visible improvements in wrinkle depth and skin firmness over eight weeks of twice-daily use.

UV Resistance Enhancement. Research indicates that Pal-GHK can improve the skin’s natural defense against UV-induced damage, supporting the integrity of the dermal ECM under photoaging conditions — a meaningful benefit for daily-use anti-aging formulations.

Excellent Tolerability. Palmitoyl Tripeptide-1 is non-irritating, non-sensitizing, and suitable for all skin types including sensitive and reactive skin. It is compatible with retinol, vitamin C, niacinamide, hyaluronic acid, and other cosmetic actives.

Palmitoyl Tripeptide-1 vs. Palmitoyl Pentapeptide-4 (Matrixyl): Which Is Better?

Palmitoyl Tripeptide-1 and Palmitoyl Pentapeptide-4 (Matrixyl) are both matrikine-mimicking collagen-signaling peptides developed by Sederma, and both are among the most widely used anti-aging peptides in prestige skincare. They share a common goal but differ in amino acid sequence, collagen targets, and typical formulation context.

Palmitoyl Tripeptide-1 (Pal-GHK, CAS 147732-56-7) is a tripeptide (Gly-His-Lys + palmitoyl), mimics a fragment of collagen type I and activates the GHK copper-binding pathway, primarily stimulates collagen types I and III plus GAGs, is the collagen-signaling component of Matrixyl 3000 (paired with Palmitoyl Tetrapeptide-7 for anti-inflammatory coverage), is used at 0.001%–0.01% w/w, and is best suited for collagen rebuilding, skin firming, hydration support, and multi-peptide complex formulations. It is the preferred choice for comprehensive Matrixyl 3000-style formulations.

Palmitoyl Pentapeptide-4 (Pal-KTTKS, CAS 214047-00-4) is a pentapeptide (Lys-Thr-Thr-Lys-Ser + palmitoyl), mimics a fragment of procollagen type I (the KTTKS sequence), primarily stimulates collagen types I and IV plus fibronectin, is the original Matrixyl (standalone), has the most extensive single-peptide clinical evidence base of any cosmetic peptide, is used at 0.001%–0.01% w/w, and is best suited for targeted collagen stimulation, wrinkle reduction, and wound healing support. It is the gold standard for standalone collagen-stimulating peptides.

Bottom line: both peptides are highly effective collagen-signaling agents. Palmitoyl Pentapeptide-4 has the stronger standalone clinical evidence base. Palmitoyl Tripeptide-1 is the preferred choice when formulating Matrixyl 3000-style complexes, where it pairs with Palmitoyl Tetrapeptide-7 to add anti-inflammatory coverage alongside collagen stimulation. For maximum anti-aging efficacy, many premium formulations combine both peptides.

Formulation and Usage Recommendations

Palmitoyl Tripeptide-1 is effective at very low concentrations: 0.001%–0.01% w/w in finished formulations. It is water-soluble and should be added to the aqueous phase during formulation at temperatures below 40°C to preserve peptide integrity. Optimal pH range is 4.0–7.5.

It is compatible with most cosmetic actives including retinol, niacinamide, vitamin C (at appropriate pH), hyaluronic acid, and other peptides. It combines synergistically with Palmitoyl Tetrapeptide-7 (to form a Matrixyl 3000-equivalent complex for combined collagen + anti-inflammatory activity), Palmitoyl Pentapeptide-4 (for broader collagen type coverage), GHK-Cu (for copper-mediated collagen remodeling and wound healing), and Acetyl Hexapeptide-3 / SNAP-8 (for expression line reduction).

Typical finished product applications include anti-aging serums, eye creams, night creams, firming moisturizers, and multi-peptide complex formulations.

Safety and Precautions

Palmitoyl Tripeptide-1 has an excellent safety profile and is approved for use in cosmetic formulations globally, including under EU Cosmetics Regulation and FDA cosmetic guidelines. It is non-toxic, non-mutagenic, and non-sensitizing at recommended use levels. A 2025 PMC safety framework review confirmed the favorable safety profile of palmitoyl-GHK in cosmetic applications, with no significant adverse reactions reported in clinical studies.

This ingredient is intended for use in topical cosmetic formulations only and is not for oral consumption. Formulators should conduct standard patch testing and stability assessments for finished products. Always consult with a qualified cosmetic chemist or dermatologist before incorporating new actives into clinical or consumer formulations. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.